Evoke Pharma, Inc. (EVOK)
NASDAQ: EVOK · Real-Time Price · USD
4.890
-0.010 (-0.20%)
Dec 26, 2024, 4:00 PM EST - Market closed
Evoke Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 8.62 | 5.18 | 2.51 | 1.62 | 0.02 | - | Upgrade
|
| Revenue Growth (YoY) | 100.35% | 106.51% | 55.04% | 6929.00% | - | - | Upgrade
|
| Cost of Revenue | 0.3 | 0.2 | 0.37 | 0.33 | 0.09 | - | Upgrade
|
| Gross Profit | 8.32 | 4.98 | 2.14 | 1.29 | -0.06 | - | Upgrade
|
| Selling, General & Admin | 14.18 | 12.23 | 9.62 | 8.85 | 6.43 | 3.74 | Upgrade
|
| Research & Development | 0.04 | 0.18 | 0.3 | 0.59 | 6.55 | 3.42 | Upgrade
|
| Operating Expenses | 14.22 | 12.41 | 9.92 | 9.44 | 12.98 | 7.15 | Upgrade
|
| Operating Income | -5.9 | -7.43 | -7.79 | -8.15 | -13.05 | -7.15 | Upgrade
|
| Interest Expense | -0.5 | -0.5 | -0.5 | -0.5 | -0.11 | - | Upgrade
|
| Interest & Investment Income | 0.25 | 0.14 | 0.06 | 0.01 | 0.01 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | -6.15 | -7.79 | -8.22 | -8.64 | -13.15 | -7.13 | Upgrade
|
| Other Unusual Items | - | - | - | 0.11 | - | - | Upgrade
|
| Pretax Income | -6.15 | -7.79 | -8.22 | -8.54 | -13.15 | -7.13 | Upgrade
|
| Net Income | -6.15 | -7.79 | -8.22 | -8.54 | -13.15 | -7.13 | Upgrade
|
| Net Income to Common | -6.15 | -7.79 | -8.22 | -8.54 | -13.15 | -7.13 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 429.66% | 6.34% | 17.21% | 26.26% | 14.33% | 34.29% | Upgrade
|
| EPS (Basic) | -4.17 | -27.97 | -31.39 | -38.20 | -74.31 | -46.02 | Upgrade
|
| EPS (Diluted) | -4.17 | -27.97 | -31.39 | -38.20 | -74.31 | -46.02 | Upgrade
|
| Free Cash Flow | -5.32 | -4.98 | -6.6 | -12.35 | -6.63 | -5.76 | Upgrade
|
| Free Cash Flow Per Share | -3.61 | -17.89 | -25.18 | -55.27 | -37.45 | -37.21 | Upgrade
|
| Gross Margin | 96.55% | 96.10% | 85.24% | 79.72% | -276.68% | - | Upgrade
|
| Operating Margin | -68.45% | -143.44% | -310.37% | -503.79% | -56678.32% | - | Upgrade
|
| Profit Margin | -71.33% | -150.41% | -327.83% | -527.66% | -57144.53% | - | Upgrade
|
| Free Cash Flow Margin | -61.79% | -96.22% | -262.93% | -763.43% | -28801.07% | - | Upgrade
|
| EBIT | -5.9 | -7.43 | -7.79 | -8.15 | -13.05 | -7.15 | Upgrade
|
| EBIT Margin | -68.45% | -143.44% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.